Dr. Wenhui Li 李文辉
Chief Physician
Department of Radiation Oncology, Yunnan Cancer Hospital, Kunming
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation therapy and comprehensive treatment, including chemotherapy, for malignant tumors such as breast cancer and lung cancer.
Dr. Li holds a master’s degree in oncology from Kunming Medical University (2002) and graduated from Shanghai Railway Medical College (1986). Training includes fellowships at New Jersey Medical School, Thomas Jefferson University Hospital, and the University of Illinois Cancer Center. Dr. Li has published over 24 papers, holds two national utility model patents, and leads or participates in six research projects.
Professional roles
- Director, Radiation Therapy Center, Yunnan Cancer Hospital
Name order: in Chinese the family name comes first (Li Wenhui). Papers usually list the name as Wenhui Li or Li W.
Selected publications
58 papers on PubMed matched by name and affiliation; 22 as first or senior author since 2016. Most recent first- or senior-author papers:
- iScience, 2026 (senior author): Local global feature enhanced transformer with attention pruning for precise medical image segmentation. PubMed 42338481
- Radiother Oncol, 2026 (senior author): ZIP10 drives radioresistance and malignant progression in lung adenocarcinoma by inhibiting the Hippo pathway via a Zinc-LATS axis. PubMed 41520732
- J Cell Mol Med, 2025 (senior author): High-Dose Ascorbic Acid Combined With Dihydroartemisinin Inhibits Lung Adenocarcinoma Malignancy by Inducing Ferroptosis via SLC7A11/GPX4 Pathway. PubMed 41451920
- Am J Med Sci, 2025 (senior author): miRNA-105-5p regulates the histone deacetylase HDAC2 through FOXG1 to affect the malignant biological behavior of triple-negative breast cancer cells. PubMed 39313115
- Heliyon, 2024 (senior author): Oxidative stress gene signature construction to identify subtypes and prognosis of patients with lung adenocarcinoma. PubMed 39640604
- Mol Immunol, 2023 (senior author): Irradiated lung cancer cell-derived exosomes modulate macrophage polarization by inhibiting MID1 via miR-4655-5p. PubMed 36709645
- Front Immunol, 2022 (senior author): The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma. PubMed 36311724
- Front Oncol, 2022 (senior author): Construction of a Novel Prognostic Model in Lung Adenocarcinoma Based on 7-Methylguanosine-Related Gene Signatures. PubMed 35785179
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion